Get started
Author

Mohamed Aseafan

Cancer Survival in Saudi Arabia 2005-2009: Analysis of the Population-Based Saudi Cancer Registry
2021 · Mohamed Aseafan, Edward Devol, et al. · Scientific Reports · 19
PDF
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study
2024 · Shouki Bazarbashi, Radwan Alkhatib, et al. · JCO Global Oncology · 13
Real-world clinical outcome of unresectable locally advanced & de-novo metastatic pancreatic ductal adenocarcinoma: a multicentre retrospective study
2025 · Mohamed Aseafan, Ali H. Alfakeeh, et al. · BMC Cancer · 7
PDF
Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer
2024 · Bader Alshamsan, Mahmoud Elshenawy, et al. · Oncology Letters · 7
PDF
Pazopanib as Treatment Option for Pseudomyogenic Hemangioendothelioma: A Case Report
2022 · Ali Alhanash, Mohamed Aseafan, et al. · Cureus · 7
PDF
Outcomes of Autologous stem cell transplantation in patients with primary refractory Diffuse Large B-cell lymphoma who demonstrate chemosensitivity to salvage chemotherapy
2024 · M Shahzad Rauf, Irfan Maghfoor, et al. · Clinical Hematology International · 5
PDF
Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre
2023 · Shouki Bazarbashi, Mohamed Aseafan, et al. · BMC Endocrine Disorders · 5
PDF
Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia
2022 · Mohammed Alghamdi, Shouki Bazarbashi, et al. · Journal of Oncology · 4
PDF
Outcomes and Prognostic Factors of Metastatic Gastric Cancer: A Single-Center Experience
2022 · Mohamed Aseafan, Ahmed Mostafa Gad, et al. · Cureus · 4
PDF
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi Arabia
2023 · Bader Alshamsan, Mohamed Aseafan, et al. · Molecular and Clinical Oncology · 3
PDF
Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer
2026 · Kristian Shtembari, Martina Catalano, et al. · Biomolecules · 2
PDF
Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors
2022 · Shouki Bazarbashi, Turkiah Alkhaldi, et al. · Cureus · 2
PDF
Patient's characteristics and outcome of small bowel adenocarcinoma in Saudi Arabia.
2021 · Bader I Alshamsan, Ahmed ali Badran, et al. · Journal of Clinical Oncology · 2
Adjuvant abemaciclib‑induced pneumonitis: A case report and review of the literature
2021 · Abdulrahman Al‑Ghabban, Aisha Al‑Shibany, et al. · World Academy of Sciences Journal · 2
PDF
Characteristic and Clinical Outcomes of Localized Gastric Cancer: A Real-World Experience
2026 · Amal Aljuhani, Mohamed Aseafan, et al. · Hematology/Oncology and Stem Cell Therapy · 1
Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia
2025 · Shouki Bazarbashi, Ahmed S. Abdelmotal, et al. · BMC Urology · 1
Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021
2025 · Edward De Vol, Shouki Bazarbashi, et al. · Journal of Hepatocellular Carcinoma · 1
PDF
P-210 Efficacy and tolerability of cetuximab 750 mg/m2 every three weeks in metastatic colorectal cancer
2023 · M. Aseafan, K. Alshammari, et al. · Annals of Oncology · 1
PDF
Thyroid Abscess in a Young Postpartum Female
2022 · Sultan Almdallaleh, Mohamed Aseafan, et al. · Cureus · 1
PDF
Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer: Distinguishing Prophylactic and Therapeutic Roles Within Contemporary Multimodal Management
2026 · Saqer Dayis, Mohammed Alshaikh, et al. · Cureus
Estimating the budget impact of introducing dostarlimab as first line in treating endometrial cancer in Saudi Arabia
2026 · Mohamed Aseafan, Faisal Azam, et al. · Journal of Medical Economics
PDF
Estimating the budget impact of introducing dostarlimab as first line in treating endometrial cancer in Saudi Arabia
2026 · Mohamed Aseafan, Faisal Azam, et al. · Figshare
266P Real-world outcomes of neuroendocrine neoplasms across seven MENA countries: A multicenter cohort of 674 patients (2020–2025)
2026 · M. Aseafan, S. Eid, et al. · Annals of Oncology
PDF
Combined Prophylactic HIPEC/IORT Versus Surgery Alone in Localized Gastric Cancer: A 14‑Year Real-World Experience From a Tertiary Center
2026 · Hadeel Elwaheidi, Ali Sheikh, et al. · SSRN Electronic Journal
Treatment Outcome and Chemoresistance-Related Factors of Low-Risk Gestational Trophoblastic Neoplasia: Results From a Tertiary Care Center in Saudi Arabia
2025 · Mohamed Aseafan, Bader Alshamsan, et al. · JCO Global Oncology
PDF
Works count: 34
Citation count: 87
H-index: 5
I10-index: 2
Year
Topic
Type